• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Association between gene expression profile, proliferation and metastasis in uveal melanoma.葡萄膜黑色素瘤的基因表达谱、增殖与转移的相关性。
Curr Eye Res. 2010 Sep;35(9):857-63. doi: 10.3109/02713683.2010.493265.
2
M2/M1 ratio of tumor associated macrophages and PPAR-gamma expression in uveal melanomas with class 1 and class 2 molecular profiles.肿瘤相关巨噬细胞的 M2/M1 比值与具有 1 类和 2 类分子特征的葡萄膜黑色素瘤中 PPAR-γ 的表达。
Exp Eye Res. 2013 Feb;107:52-8. doi: 10.1016/j.exer.2012.11.012. Epub 2012 Nov 30.
3
Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma.转移性原发性葡萄膜黑色素瘤中3号染色体的伴随性缺失以及1号、6号或8号染色体的整条臂的缺失和增加。
Invest Ophthalmol Vis Sci. 2001 Feb;42(2):313-7.
4
Chromosomal 3 and 8 status within hepatic metastasis of uveal melanoma.葡萄膜黑色素瘤肝转移灶内的3号和8号染色体状态
Arch Pathol Lab Med. 2009 Aug;133(8):1223-7. doi: 10.5858/133.8.1223.
5
Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type.p53诱导的凋亡效应因子PERP在原发性葡萄膜黑色素瘤中的表达:下调与侵袭性类型相关。
Exp Eye Res. 2006 Oct;83(4):911-9. doi: 10.1016/j.exer.2006.04.016. Epub 2006 Jun 19.
6
Cytogenetics of uveal melanoma: a 7-year clinical experience.葡萄膜黑色素瘤的细胞遗传学:7年临床经验
Ophthalmology. 2007 Oct;114(10):1925-31. doi: 10.1016/j.ophtha.2007.06.012. Epub 2007 Aug 27.
7
MicroRNA expression analysis and Multiplex ligation-dependent probe amplification in metastatic and non-metastatic uveal melanoma.微小 RNA 表达分析和多重连接依赖性探针扩增在转移性和非转移性葡萄膜黑色素瘤中的研究。
Acta Ophthalmol. 2014 Sep;92(6):541-9. doi: 10.1111/aos.12322. Epub 2013 Dec 24.
8
Personalized Prognosis of Uveal Melanoma Based on Cytogenetic Profile in 1059 Patients over an 8-Year Period: The 2017 Harry S. Gradle Lecture.基于 8 年 1059 例患者细胞遗传学特征的葡萄膜黑色素瘤个体化预后:2017 年哈里 S.格拉德讲座。
Ophthalmology. 2017 Oct;124(10):1523-1531. doi: 10.1016/j.ophtha.2017.04.003. Epub 2017 May 7.
9
A metastasis modifier locus on human chromosome 8p in uveal melanoma identified by integrative genomic analysis.通过整合基因组分析确定的葡萄膜黑色素瘤中人类8号染色体短臂上的转移修饰位点。
Clin Cancer Res. 2008 Jun 15;14(12):3737-45. doi: 10.1158/1078-0432.CCR-07-5144.
10
Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma.协作性眼肿瘤学组报告第 1 号:在葡萄膜黑色素瘤中前瞻性验证多基因预后检测。
Ophthalmology. 2012 Aug;119(8):1596-603. doi: 10.1016/j.ophtha.2012.02.017. Epub 2012 Apr 21.

引用本文的文献

1
Pathological and Molecular Diagnosis of Uveal Melanoma.葡萄膜黑色素瘤的病理与分子诊断
Diagnostics (Basel). 2024 May 2;14(9):958. doi: 10.3390/diagnostics14090958.
2
Preferentially Expressed Antigen in Melanoma Immunohistochemistry Labeling in Uveal Melanomas.葡萄膜黑色素瘤中黑色素瘤免疫组织化学标记中的优先表达抗原
Ocul Oncol Pathol. 2022 Jun;8(2):133-140. doi: 10.1159/000524051. Epub 2022 Mar 11.
3
Metastatic Risk Factors Associated with Class 1A Uveal Melanoma Patients.与1A类葡萄膜黑色素瘤患者相关的转移风险因素
Cancers (Basel). 2021 Jun 30;13(13):3292. doi: 10.3390/cancers13133292.
4
Aberrant MicroRNA Expression and Its Implications for Uveal Melanoma Metastasis.异常微小RNA表达及其对葡萄膜黑色素瘤转移的影响。
Cancers (Basel). 2019 Jun 12;11(6):815. doi: 10.3390/cancers11060815.
5
Oral administration of the selective GPR120/FFA4 agonist compound A is not effective in alleviating tissue inflammation in mouse models of prototypical autoimmune diseases.口服选择性 GPR120/FFA4 激动剂化合物 A 不能有效缓解典型自身免疫性疾病小鼠模型中的组织炎症。
Pharmacol Res Perspect. 2018 Nov 8;6(6):e00438. doi: 10.1002/prp2.438. eCollection 2018 Dec.
6
The digital age of melanoma management: detection and diagnostics.黑色素瘤管理的数字时代:检测与诊断
Melanoma Manag. 2015 Nov;2(4):383-391. doi: 10.2217/mmt.15.31. Epub 2015 Nov 26.
7
Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis.使用葡萄膜黑色素瘤肝转移建立原位患者来源的异种移植小鼠模型。
J Transl Med. 2017 Jun 23;15(1):145. doi: 10.1186/s12967-017-1247-z.
8
Focus on cutaneous and uveal melanoma specificities.关注皮肤和葡萄膜黑色素瘤的特异性。
Genes Dev. 2017 Apr 15;31(8):724-743. doi: 10.1101/gad.296962.117.
9
Using risk factors for detection and prognostication of uveal melanoma.利用危险因素进行葡萄膜黑色素瘤的检测和预后评估。
Indian J Ophthalmol. 2015 Feb;63(2):110-6. doi: 10.4103/0301-4738.154373.
10
Current clinical practice: differential management of uveal melanoma in the era of molecular tumor analyses.当前临床实践:分子肿瘤分析时代葡萄膜黑色素瘤的差异化管理
Clin Ophthalmol. 2014 Dec 3;8:2449-60. doi: 10.2147/OPTH.S70839. eCollection 2014.

本文引用的文献

1
Cell cycle, CDKs and cancer: a changing paradigm.细胞周期、细胞周期蛋白依赖性激酶与癌症:不断变化的范式
Nat Rev Cancer. 2009 Mar;9(3):153-66. doi: 10.1038/nrc2602.
2
A metastasis modifier locus on human chromosome 8p in uveal melanoma identified by integrative genomic analysis.通过整合基因组分析确定的葡萄膜黑色素瘤中人类8号染色体短臂上的转移修饰位点。
Clin Cancer Res. 2008 Jun 15;14(12):3737-45. doi: 10.1158/1078-0432.CCR-07-5144.
3
Prognostic biomarkers in uveal melanoma: evidence for a stem cell-like phenotype associated with metastasis.葡萄膜黑色素瘤的预后生物标志物:与转移相关的干细胞样表型的证据。
Melanoma Res. 2008 Jun;18(3):191-200. doi: 10.1097/CMR.0b013e3283005270.
4
Integrative genomic analysis of aneuploidy in uveal melanoma.葡萄膜黑色素瘤非整倍体的综合基因组分析
Clin Cancer Res. 2008 Jan 1;14(1):115-22. doi: 10.1158/1078-0432.CCR-07-1825.
5
Transcriptomic versus chromosomal prognostic markers and clinical outcome in uveal melanoma.葡萄膜黑色素瘤的转录组学与染色体预后标志物及临床结局
Clin Cancer Res. 2007 Mar 1;13(5):1466-71. doi: 10.1158/1078-0432.CCR-06-2401.
6
Functional gene expression analysis uncovers phenotypic switch in aggressive uveal melanomas.功能基因表达分析揭示侵袭性葡萄膜黑色素瘤的表型转换。
Cancer Res. 2006 May 1;66(9):4602-9. doi: 10.1158/0008-5472.CAN-05-4196.
7
KI-67 immunopositivity in choroidal and ciliary body melanoma with respect to nucleolar diameter and other prognostic factors.脉络膜和睫状体黑色素瘤中KI-67免疫阳性与核仁直径及其他预后因素的关系
Curr Eye Res. 2006 Jan;31(1):57-67. doi: 10.1080/02713680500478535.
8
Association between microarray gene expression signature and extravascular matrix patterns in primary uveal melanomas.原发性葡萄膜黑色素瘤中基因芯片基因表达特征与血管外基质模式之间的关联。
Am J Ophthalmol. 2005 Oct;140(4):748-9. doi: 10.1016/j.ajo.2005.04.024.
9
Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death.葡萄膜黑色素瘤中的基因表达谱揭示了两种分子类别,并可预测转移性死亡。
Cancer Res. 2004 Oct 15;64(20):7205-9. doi: 10.1158/0008-5472.CAN-04-1750.
10
p53 Immunoreactivity, Ki-67 expression, and microcirculation patterns in melanoma of the iris, ciliary body, and choroid.虹膜、睫状体和脉络膜黑色素瘤中的p53免疫反应性、Ki-67表达及微循环模式
Curr Eye Res. 2002 Feb;24(2):105-8. doi: 10.1076/ceyr.24.2.105.8166.

葡萄膜黑色素瘤的基因表达谱、增殖与转移的相关性。

Association between gene expression profile, proliferation and metastasis in uveal melanoma.

机构信息

Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri 63110, USA.

出版信息

Curr Eye Res. 2010 Sep;35(9):857-63. doi: 10.3109/02713683.2010.493265.

DOI:10.3109/02713683.2010.493265
PMID:20795869
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3230327/
Abstract

PURPOSE

Uveal melanomas cluster into two molecular groups based on their gene expression profile. Tumors with the class 1 signature rarely metastasize, whereas those with the class 2 signature have a very high rate of metastasis. However, the biological basis for this metastatic propensity of class 2 tumors remains unclear. Towards such an explanation, this study was conducted to determine whether class 2 tumors have a higher proliferative rate than class 1 tumors.

MATERIALS AND METHODS

The study included 28 primary uveal melanomas with extensive clinical, pathologic, and genetic annotation, including age, gender, ciliary body involvement, tumor basal diameter, thickness, cell type, gene expression profile, status of chromosomes 3 and 8p, aneuploidy, and clinical outcome. Immunopositivity for Ki-67 was determined by counting all positive nuclei in representative whole tumor sections.

RESULTS

Ki-67 positivity was significantly associated with class 2 gene expression profile, loss of chromosome 3 and increased aneuploidy (P = 0.04, P = 0.004, and P = 0.03, respectively). Ki-67 positivity showed a borderline significant association with epithelioid cell type (P = 0.07). Receiver operating characteristic (ROC) analysis of Ki-67 positivity, using the class 2 signature as an endpoint, identified a Ki-67 score of approximately 20 cells per high power field as the optimal cut-off point between low and high risk for metastasis (log rank test, P = 0.01).

CONCLUSIONS

On average, class 2 uveal melanomas have a higher proliferative rate than class 1 tumors. Further work is needed to determine whether loss of chromosome 3, increased aneuploidy, or other factors may be responsible for the increased proliferation.

摘要

目的

葡萄膜黑色素瘤根据其基因表达谱分为两个分子群。具有 1 类特征的肿瘤很少转移,而具有 2 类特征的肿瘤转移率非常高。然而,2 类肿瘤转移倾向的生物学基础尚不清楚。基于这一解释,本研究旨在确定 2 类肿瘤是否比 1 类肿瘤具有更高的增殖率。

材料和方法

该研究纳入了 28 例原发性葡萄膜黑色素瘤,具有广泛的临床、病理和遗传注释,包括年龄、性别、睫状体受累、肿瘤基底直径、厚度、细胞类型、基因表达谱、3 号染色体和 8p 状态、非整倍体和临床结果。通过在代表性全肿瘤切片中计数所有阳性核来确定 Ki-67 的免疫阳性。

结果

Ki-67 阳性与 2 类基因表达谱、3 号染色体缺失和非整倍体增加显著相关(P=0.04、P=0.004 和 P=0.03)。Ki-67 阳性与上皮样细胞类型呈边界显著相关(P=0.07)。使用 2 类特征作为终点,Ki-67 阳性的 ROC 分析确定了大约 20 个细胞/高倍视野的 Ki-67 评分作为低风险和高风险转移的最佳分界点(对数秩检验,P=0.01)。

结论

平均而言,2 类葡萄膜黑色素瘤的增殖率高于 1 类肿瘤。需要进一步研究以确定 3 号染色体缺失、非整倍体增加或其他因素是否可能导致增殖增加。